Merit Medical continues to outperform, with the share price supported by on-target financial results, incremental M&A, and ...

Pacer US Small Cap Cash Cows 100 ETF struggles amid market malaise. Learn why CALF is underperforming and lacks appeal in the ...

Primerica thrives on a low-capital, high-margin model for middle-income families. Read why PRI stock has strong potential ...

Prologis, the largest REIT by market cap, excels in logistics and industrial real estate. Check out why I rate PLD stock a ...

Tilray's balance sheet has improved, reducing net debt significantly, which enhances its financial stability. See why I rate ...

Explore DNOW's Q4 2024 performance with EPS beats and growth insights amid international challenges. Read more here.

BigBear.ai's minimal growth and ongoing losses make it expensive. Learn why BBAI stock is a Hold, with high short interest ...

Bekaert's (BEKSF) 2024 results were robust, with a reported net profit of 238.9M EUR. Read why I maintain my buy rating on ...

Fresenius SE's restructuring and dividend reinstatement signal strong growth. Read why FSNUF stock may not be a long-term buy ...

Japan Tobacco delivers steady income with a 5% yield. Read why JAPAY stock could provide consistent returns and potential for ...

Advanced Drainage Systems’ margin declines signal potential challenges. Read why WMS stock is overpriced at 18 times earnings ...

The recent tech sell-off hammered Credo investors, but it could have bottomed out last week. Read why I maintain my buy ...